FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

21120411000001109: Repinex XL 4mg tablets (Aspire Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Sep 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
70513701000001110 Repinex XL 4mg tablets (Aspire Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
70513801000001118 Repinex XL 4mg tablets (Aspire Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Repinex XL 4mg tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Repinex XL 4mg tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Repinex XL 4mg tablets (Aspire Pharma Ltd) Is a Ropinirole 4mg modified-release tablets true Inferred relationship Existential restriction modifier
Repinex XL 4mg tablets (Aspire Pharma Ltd) Has active ingredient Ropinirole true Inferred relationship Existential restriction modifier
Repinex XL 4mg tablets (Aspire Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Repinex XL 4mg tablets (Aspire Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Repinex XL 4mg tablets (Aspire Pharma Ltd) Has specific active ingredient Ropinirole hydrochloride true Inferred relationship Existential restriction modifier
Repinex XL 4mg tablets (Aspire Pharma Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Repinex XL 4mg tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ropinirole true Inferred relationship Existential restriction modifier
Repinex XL 4mg tablets (Aspire Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Repinex XL 4mg tablets (Aspire Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Repinex XL 4mg tablets (Aspire Pharma Ltd) Is a Repinex XL true Inferred relationship Existential restriction modifier
Repinex XL 4mg tablets (Aspire Pharma Ltd) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Repinex XL 4mg tablets (Aspire Pharma Ltd) Has basis of strength substance Ropinirole true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Repinex XL 4mg tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets Has AMP True Repinex XL 4mg tablets (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start